Crossmark

Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments

Crossref DOI link: https://doi.org/10.1038/s41598-020-75840-w

Published Online: 2020-11-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Vagima, Yaron

Gur, David

Erez, Noam

Achdout, Hagit

Aftalion, Moshe

Levy, Yinon

Zauberman, Ayelet

Tidhar, Avital

Gutman, Hila

Lazar, Shlomi

Israely, Tomer

Paran, Nir

Melamed, Sharon

Brosh-Nissimov, Tal

Chitlaru, Theodor

Sagi, Irit

Mamroud, Emanuelle
Funding

Funding for this research was provided by:

IIBR (SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14, SB/5112-14)
License Information

Text and Data Mining valid from 2020-11-05

Version of Record valid from 2020-11-05
More Information

Article History

Received: 25 May 2020

Accepted: 21 October 2020

First Online: 5 November 2020

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below